Schrodinger is transforming the way therapeutics and materials are discovered. The company sells its software solutions to biopharmaceutical and industrial companies, academic institutions, and government laboratories. The company also applies its computational platform to a broad pipeline of drug discovery programs in collaboration with biopharmaceutical companies. The company operations through two segments: Software and Drug Discovery.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.